Vanda Pharmaceuticals's top three insider shareholders as of May 14, 2026 are Mihael Hristos Polymeropoulos (President And Ceo, 2.70Mn shares), Gunther Birznieks (Svp, Business Development, 494.20K shares), Kevin Patrick Moran (Svp, Cfo Treasurer, 411.38K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Mihael Hristos Polymeropoulos | President And Ceo | 2,704,496 | 0 | 04 Mar, 2026 |
| Gunther Birznieks | Svp, Business Development | 494,197 | 0 | 04 Mar, 2026 |
| Kevin Patrick Moran | Svp, Cfo Treasurer | 411,380 | 0 | 04 Mar, 2026 |
| Timothy Williams | Svp General Counsel | 377,450 | 0 | 04 Mar, 2026 |
| Timothy Williams | Svp General Counsel | 377,450 | 0 | 04 Mar, 2026 |
| Joakim Wijkstrom | Svp, Chief Marketing Officer | 333,469 | 0 | 04 Mar, 2026 |
| Joakim Wijkstrom | Svp, Chief Marketing Officer | 333,469 | 0 | 04 Mar, 2026 |
| Richard W Dugan | - | 177,454 | 0 | 09 Jun, 2025 |
| Phaedra Chrousos | - | 123,350 | 0 | 09 Jun, 2025 |
| Anne Sempowski Ward | - | 119,067 | 0 | 09 Jun, 2025 |
| Anne Sempowski Ward | - | 119,067 | 0 | 09 Jun, 2025 |
| Stephen Ray Mitchell | - | 97,082 | 0 | 16 Jun, 2025 |
| Tage Honore | - | 93,469 | 0 | 24 Feb, 2026 |
| Aranthan Ii Jones | Chief Corp. Affairs Officer | 81,980 | 0 | 17 Sep, 2021 |
| Thomas Watkins | - | 63,064 | 0 | 03 Jun, 2022 |
| Thomas Watkins | - | 63,064 | 0 | 03 Jun, 2022 |
| Charles Cliff Duncan | - | 57,101 | 0 | 24 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 22 Apr, 2026 | Charles Cliff Duncan | Common Stock | A | 57,101 | $0.00 | 57,101 | D | A |
| 22 Apr, 2026 | Charles Cliff Duncan | Common Stock | A | 57,101 | $0.00 | 57,101 | D | A |
| 22 Apr, 2026 | Charles Cliff Duncan | Common Stock | A | 57,101 | $0.00 | 57,101 | D | A |
| 22 Apr, 2026 | Charles Cliff Duncan | Common Stock | A | 57,101 | $0.00 | 57,101 | D | A |
| 22 Apr, 2026 | Charles Cliff Duncan | Common Stock | A | 57,101 | $0.00 | 57,101 | D | A |
| 02 Mar, 2026 | Joakim Wijkstrom | Common Stock | D | 30,800 | $8.27 | 333,469 | D | S |
| 02 Mar, 2026 | Gunther Birznieks | Common Stock | D | 42,431 | $8.27 | 494,197 | D | S |
| 02 Mar, 2026 | Timothy Williams | Common Stock | D | 42,434 | $8.27 | 377,450 | D | S |
| 02 Mar, 2026 | Kevin Patrick Moran | Common Stock | D | 42,442 | $8.27 | 411,380 | D | S |
| 02 Mar, 2026 | Mihael Hristos Polymeropoulos | Common Stock | D | 156,235 | $8.17 | 2,704,496 | D | S |
| 23 Feb, 2026 | Tage Honore | Common Stock | D | 30,000 | $8.03 | 93,469 | D | S |
| 18 Feb, 2026 | Mihael Hristos Polymeropoulos | Common Stock | A | 525,000 | $0.00 | 2,860,731 | D | A |
| 18 Feb, 2026 | Joakim Wijkstrom | Common Stock | A | 125,000 | $0.00 | 364,269 | D | A |
| 18 Feb, 2026 | Kevin Patrick Moran | Common Stock | A | 125,000 | $0.00 | 453,822 | D | A |
| 18 Feb, 2026 | Gunther Birznieks | Common Stock | A | 125,000 | $0.00 | 536,628 | D | A |
| 18 Feb, 2026 | Timothy Williams | Common Stock | A | 125,000 | $0.00 | 419,884 | D | A |
| 07 Aug, 2025 | Mihael Hristos Polymeropoulos | Common Stock | A | 10,000 | $4.15 | 2,335,731 | D | P |
| 13 Jun, 2025 | Stephen Ray Mitchell | Common Stock | D | 7,000 | $4.59 | 97,082 | D | S |
| 05 Jun, 2025 | Stephen Ray Mitchell | Common Stock | A | 59,225 | $0.00 | 104,082 | D | A |
| 05 Jun, 2025 | Richard W Dugan | Common Stock | A | 59,225 | $0.00 | 177,454 | D | A |